Revelation Biosciences, Inc. (REVB)
NASDAQ: REVB · Real-Time Price · USD
0.295
-0.020 (-6.23%)
At close: Dec 20, 2024, 4:00 PM
0.310
+0.015 (5.08%)
After-hours: Dec 20, 2024, 6:58 PM EST

Revelation Biosciences Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2023 FY 2022 FY 2021 FY 2020
Period Ending
Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
Market Capitalization
1346793
Market Cap Growth
-67.76%-29.53%-93.31%-28.41%-
Enterprise Value
-5-11-270-
Last Close Price
0.2915.02199.6110710.0210552.52
PB Ratio
0.470.474.25-671.9727.37
P/TBV Ratio
0.520.474.25-31.04
Debt / Equity Ratio
----0.17-
Quick Ratio
1.612.151.180.603.72
Current Ratio
1.642.181.220.893.82
Return on Equity (ROE)
-270.02%-3.12%-2272.77%-723.81%-
Return on Assets (ROA)
-50.98%-61.08%-179.98%-224.21%-
Return on Capital (ROIC)
-92.97%-140.53%-1400.45%-448.74%-
Earnings Yield
-1225.30%-3.81%-242.05%-17.93%-4.07%
FCF Yield
-1311.99%-231.09%-250.76%-16.79%-2.28%
Buyback Yield / Dilution
-525.77%-215.00%---
Total Shareholder Return
-525.77%-215.00%---
Source: S&P Capital IQ. Standard template. Financial Sources.